These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 14686282)

  • 1. Hope for AIDS vaccine fades with news of superinfection.
    AIDS Policy Law; 2002 Aug; 17(14):2. PubMed ID: 14686282
    [No Abstract]   [Full Text] [Related]  

  • 2. Grim news for vaccine.
    AIDS Patient Care STDS; 2002 Oct; 16(10):513-4. PubMed ID: 12442739
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV vaccine best hope for controlling AIDS, says NNIH.
    AIDS Policy Law; 2002 Jun; 17(11):2. PubMed ID: 12083036
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccine against three kinds of HIV begins human tests.
    AIDS Treat News; 2002 Nov; (385):4. PubMed ID: 12492040
    [No Abstract]   [Full Text] [Related]  

  • 5. Scientists document increasing reports of HIV superinfection.
    AIDS Read; 2003 Sep; 13(9):414. PubMed ID: 14598786
    [No Abstract]   [Full Text] [Related]  

  • 6. Superinfections create further HIV vaccine complications.
    Expert Rev Anti Infect Ther; 2003 Aug; 1(2):199. PubMed ID: 15482113
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccine news is disappointing.
    AIDS Patient Care STDS; 2004 Apr; 18(4):253. PubMed ID: 15154413
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible HIV vaccine stirs hope.
    Dent Today; 1997 Jan; 16(1):35. PubMed ID: 9560624
    [No Abstract]   [Full Text] [Related]  

  • 9. Even an HIV vaccine may not mean the end of AIDS.
    Muula AS
    Bull World Health Organ; 2001; 79(3):269. PubMed ID: 11285679
    [No Abstract]   [Full Text] [Related]  

  • 10. More bad news on vaccine trials.
    AIDS Patient Care STDS; 2007 Nov; 21(11):890-1. PubMed ID: 18338432
    [No Abstract]   [Full Text] [Related]  

  • 11. Is it really time to give up on the hope of finding a preventative HIV vaccine? Experts offer a mixed review of the vaccine's future.
    AIDS Alert; 2008 May; 23(5):49-52. PubMed ID: 18637256
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV-1 group M superinfection in an HIV-1 group O-infected patient.
    Plantier JC; Lemée V; Dorval I; Gueudin M; Braun J; Hutin P; Ruffault A; Simon F
    AIDS; 2004 Dec; 18(18):2444-6. PubMed ID: 15622327
    [No Abstract]   [Full Text] [Related]  

  • 13. Hope marks annual HIV vaccine awareness event.
    AIDS Policy Law; 2005 Jun; 20(11):2. PubMed ID: 15966065
    [No Abstract]   [Full Text] [Related]  

  • 14. Researchers: focus shifts for HIV vaccine hunt.
    AIDS Policy Law; 2007 Sep; 22(18):9. PubMed ID: 18203396
    [No Abstract]   [Full Text] [Related]  

  • 15. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
    Emini EA; Koff WC
    Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV-1 superinfection.
    Waters L; Smit E
    Curr Opin Infect Dis; 2012 Feb; 25(1):42-50. PubMed ID: 22156898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AIDS vaccine development and challenge viruses: getting real.
    Vlasak J; Ruprecht RM
    AIDS; 2006 Nov; 20(17):2135-40. PubMed ID: 17086052
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress and obstacles in the development of an AIDS vaccine.
    Letvin NL
    Nat Rev Immunol; 2006 Dec; 6(12):930-9. PubMed ID: 17124514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of HIV vaccine trial participation: an Indian perspective.
    Sahay S; Mehendale S; Sane S; Brahme R; Brown A; Charron K; Beyrer C; Bollinger R; Paranjape R
    Vaccine; 2005 Feb; 23(11):1351-8. PubMed ID: 15661383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The challenges of HIV vaccine development and testing.
    Burgers WA; Williamson C
    Best Pract Res Clin Obstet Gynaecol; 2005 Apr; 19(2):277-91. PubMed ID: 15778116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.